US Stock MarketDetailed Quotes

NBRVF Nabriva Therapeutics PLC

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Jan 2 16:00 ET
3.23Market Cap0.00P/E (TTM)

Nabriva Therapeutics PLC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/Q2
Stock NameRevenueRatio
Product revenue, net2.57M114.76%
Research premium and grant revenue-331K-14.76%
Region Currency:USD
2022/FY
Stock NameRevenueRatio
United States36.94M100.00%
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Collegium Pharmaceutical
COLL
+14.41%
eBay
EBAY
+9.86%
Halozyme Therapeutics
HALO
+5.02%
SilverCrest Metals
SILV
+4.63%
Workday
WDAY
+2.01%

Unlock the Full List